PRF Technologies (PRFX) Cash & Equivalents (2019 - 2025)
PRF Technologies' (PRFX) quarterly Cash & Equivalents came in at $3.1 million in Q4 2025, down 26.66% YoY from $4.3 million in Q4 2024, and down 10.56% on a QoQ basis from $3.5 million in Q2 2025.
PRF Technologies (PRFX) Cash & Equivalents (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has 7 years of Cash & Equivalents data on file, last reported at $3.1 million in Q4 2025.
- Quarterly Cash & Equivalents fell 26.66% year-over-year to $3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (down 26.66% YoY) and the FY2025 annual result came in at $3.1 million, down 26.66% from the prior year.
- Cash & Equivalents retreated to $3.1 million in Q4 2025, from $3.5 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $19.4 million in Q1 2021 to a low of $2.8 million in Q2 2024.
- A 5-year average of $9.4 million and a median of $7.6 million in 2023 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2021 — Cash & Equivalents jumped 3137.09% — and 2022, when it tumbled 75.23%.
- Tracing PRFX's Cash & Equivalents over 5 years: stood at $16.5 million in 2021, then plunged by 75.23% to $4.1 million in 2022, then soared by 95.95% to $8.0 million in 2023, then slumped by 46.91% to $4.3 million in 2024, then declined by 26.66% to $3.1 million in 2025.
- The last three Cash & Equivalents figures came in at $3.1 million (Q4 2025), $3.5 million (Q2 2025), and $4.3 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | 3.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.13 Mn |
| Jun 30, 2025 | 3.49 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Mar 31, 2024 | 4.33 Mn |
| Dec 31, 2023 | 8.03 Mn |
| Sep 30, 2023 | 7.56 Mn |
| Jun 30, 2023 | 5.15 Mn |
| Mar 31, 2023 | 8.15 Mn |
| Dec 31, 2022 | 4.10 Mn |
| Sep 30, 2022 | 6.95 Mn |
| Jun 30, 2022 | 13.87 Mn |
| Mar 31, 2022 | 16.57 Mn |
| Dec 31, 2021 | 16.54 Mn |
| Sep 30, 2021 | 18.34 Mn |
| Jun 30, 2021 | 17.80 Mn |
| Mar 31, 2021 | 19.44 Mn |
| Dec 31, 2020 | 15.68 Mn |
| Sep 30, 2020 | 17.72 Mn |
| Jun 30, 2020 | 550,000.00 |